What is Exagen Inc (XGN) stock price today?

Exagen Inc (XGN) currently trades at $2.90 per share. The stock has a market capitalization of $65.91M and a P/E ratio of —x.

Is XGN stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Exagen Inc has a Smart Value Score of 36/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Exagen Inc's revenue and earnings?

Exagen Inc has trailing twelve-month (TTM) revenue of $66.58M with profit margins of -30.00%. Earnings per share (EPS) is $-0.93.

Is XGN stock overvalued or undervalued?

Based on our DCF model, Exagen Inc's intrinsic value is $10.28, representing a margin of safety of 67.90%. The stock currently trades at a P/E of —x.

XGN

Exagen Inc

NASDAQ: XGN · HEALTHCARE · DIAGNOSTICS & RESEARCH

$2.90

+5.07% today

Updated 2026-04-30

Market cap

$65.91M

P/E ratio

—

P/S ratio

0.99x

EPS (TTM)

$-0.93

Dividend yield

—

52W range

$3 – $12

Volume

0.3M

Market cap

$65.91M

P/E ratio

—

P/S ratio

0.99x

EPS (TTM)

$-0.93

Dividend yield

—

52W range

$3 – $12

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

6.7

Growth

5.0

Quality

C+

2.0

Profitability

6.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$8.67

+198.97%

12-Month target

—

Intrinsic (DCF)

$10.28

Margin of safety

+67.90%

0 Strong Buy7 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 21.80% QoQ

+ 67.90% below intrinsic value

Risks

- Thin margins at -30.00%

- Negative free cash flow $-3.06M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$45.56M	$52.55M	$55.64M	$66.58M	$66.58M
Net income	$-47.39M	$-23.69M	$-15.12M	$-19.95M	$-4.67M
EPS	—	—	—	—	$-0.93
Free cash flow	$-36.46M	$-15.29M	$-13.79M	$-14.27M	$-3.06M
Profit margin	-104.00%	-45.08%	-27.17%	-29.97%	-30.00%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
XGN	$65.91M	36	6.7	2.0	6.7	5.0	+67.90%	Hold
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Exagen Inc trades at $2.90. Our Smart Value Score of 36/100 indicates the stock is weak. TTM revenue stands at $66.58M. with profit margins at -30.00%. Our DCF model estimates intrinsic value at $10.28.

Frequently asked questions

What is Exagen Inc's stock price?

Exagen Inc (XGN) trades at $2.90.

Is Exagen Inc overvalued?

Smart Value Score 36/100 (Grade D, Sell). DCF value $10.28.

What is the price target of Exagen Inc (XGN)?

The analyst target price is $8.67, representing +199.0% upside from the current price of $2.90.

What is the intrinsic value of Exagen Inc (XGN)?

Based on our DCF model, intrinsic value is $10.28, a +67.9% margin of safety versus $2.90.

What is Exagen Inc's revenue?

TTM revenue is $66.58M.

Company info

SectorHEALTHCARE

IndustryDIAGNOSTICS & RESEARCH

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio0.99x

ROE-147.80%

Beta1.94

50D MA$3.12

200D MA$6.93

Shares out0.02B

Float0.02B

Short ratio—

Avg volume0.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

XGN vs LLY →XGN vs JNJ →XGN vs ABBV →Stock screener →